title: Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON.
authors.forename: S
authors.initials: S
authors.lastname: Daenen
authors.forename: B
authors.initials: B
authors.lastname: van der Holt
authors.forename: A W
authors.initials: AW
authors.lastname: Dekker
authors.forename: R
authors.initials: R
authors.lastname: Willemze
authors.forename: A W
authors.initials: AW
authors.lastname: Rijneveld
authors.forename: B J
authors.initials: BJ
authors.lastname: Biemond
authors.forename: P
authors.initials: P
authors.lastname: Muus
authors.forename: A A
authors.initials: AA
authors.lastname: van de Loosdrecht
authors.forename: H C
authors.initials: HC
authors.lastname: Schouten
authors.forename: M
authors.initials: M
authors.lastname: van Marwijk Kooy
authors.forename: D A
authors.initials: DA
authors.lastname: Breems
authors.forename: H
authors.initials: H
authors.lastname: Demuynck
authors.forename: J
authors.initials: J
authors.lastname: Maertens
authors.forename: P W
authors.initials: PW
authors.lastname: Wijermans
authors.forename: S
authors.initials: S
authors.lastname: Wittebol
authors.forename: E W
authors.initials: EW
authors.lastname: de Klerk
authors.forename: J J
authors.initials: JJ
authors.lastname: Cornelissen
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000401:mortality*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality*; D011379:Prognosis; D011446:Prospective Studies; D015996:Survival Rate